why choose us

First received: December 06, 2024

Clinical Trial: A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Liver Fibrosis

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Randomised, Single-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics and Explore the Pharmacodynamic Effects of AZD2389 in Participants With Liver

Brief Summary: The purpose of this study is to measure the safety, tolerability, and the way the body absorbs, distributes, and metabolises AZD2389 as compared to placebo in participants with liver fibrosis and compensated cirrhosis.The study will also examine how the drug acts on the body

Read more